EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY 4.0

Comparing the Effects of Premedication With Low‐Dose Midazolam, Low‐Dose Etomidate, and Transcutaneous Acupoint Electrical Stimulation on Reducing Etomidate‐Induced Myoclonic Movements and Pain: A Single‐Blind Randomized Clinical Trial

Mehran Rezvani Habibiabadi iD, Behzad Nazemroaya iD, Reza Tanhaei

Anesthesiology Research and Practice · 2026-01 · 2026 (1)

DOI: 10.1155/anrp/5199717 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Anesthesiology Research and Practice, online erschienen am 14.11.2026. Verfasst von Mehran Rezvani Habibiabadi und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Critical Care School of Medicine Isfahan University of Medical Sciences Isfahan Iran mui.ac.ir. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

Etomidate is a short‐acting intravenous hypnotic widely used for anesthetic induction because of its favorable hemodynamic profile. However, etomidate frequently causes injection pain and myoclonic movements, which may lead to clinically relevant complications in susceptible patients. This randomized clinical trial evaluated whether premedication with low‐dose midazolam, low‐dose etomidate, or transcutaneous acupoint electrical stimulation (TAES) reduces etomidate‐induced myoclonus and injection pain compared with control in adults undergoing elective surgery.

Methods

In this single‐blind (assessor‐blinded), randomized, parallel‐group clinical trial, 92 adult patients (18–60 years, ASA physical Status I–II) scheduled for elective surgical procedures at Kashani Hospital (Isfahan, Iran) were allocated to four groups ( n = 23 each): control (normal saline), midazolam (0.15 mg/kg), etomidate (0.03 mg/kg), and TAES. TAES was applied bilaterally to the Hegu (LI4), Neiguan (PC6), and Zusanli (ST36) acupoints 30 min before etomidate injection. Injection pain was assessed using the Ambesh Four‐Point Behavioral Scale. The presence, severity (0–3), and duration (< 5 s, 5–10 s, > 10 s) of etomidate‐induced myoclonic movements were recorded. Hemodynamic parameters were monitored at predefined time points. The primary outcome was the combined incidence of injection pain and myoclonic movements during etomidate administration. Secondary outcomes included myoclonus severity and duration, individual pain and myoclonus scores, periprocedural hemodynamics, and adverse events. Statistical analysis used chi‐square or Fisher’s exact tests and one‐way ANOVA, with p < 0.05 considered significant.

Results

Ninety‐two patients completed the trial (23 per group). Age, height, weight, and baseline hemodynamic parameters were comparable among groups, whereas sex distribution and the prevalence of some comorbidities differed significantly. The incidence of injection pain differed significantly among groups ( p = 0.006): 17.4% ( n = 4) of patients in the control group exhibited behavioral signs of pain, whereas no injection pain was observed in the midazolam, etomidate, or TAES groups. Myoclonic movements were observed in 60.9% ( n = 14) of patients in the control group, compared with 26.1% ( n = 6), 39.1% ( n = 9), and 34.8% ( n = 8) in the etomidate, midazolam, and TAES groups, respectively ( p = 0.099). The incidence of the composite primary outcome (defined as injection pain and/or myoclonus) was 60.9% in the control group, compared with 26.1%, 39.1%, and 34.8% in the etomidate, midazolam, and TAES groups, respectively. Compared with control, the risk of the composite endpoint was reduced in all intervention groups (etomidate RR 0.43, 95% CI 0.20–0.92; midazolam RR 0.64, 95% CI 0.35–1.18; TAES RR 0.57, 95% CI 0.30–1.09). The distribution of myoclonus severity ( p = 0.180) and duration ( p = 0.180) did not differ significantly between groups. No clinically relevant hemodynamic instability, respiratory depression, or major complications were observed.

Conclusion

Premedication with low‐dose midazolam, low‐dose etomidate, or TAES completely prevented observable injection pain and produced a clinically meaningful, though statistically nonsignificant, reduction in the incidence of etomidate‐induced myoclonic movements compared with control, without compromising hemodynamic stability. These interventions may represent safe and practical strategies to mitigate common adverse effects associated with etomidate; however, larger multicenter trials are warranted to confirm their efficacy for preventing myoclonus. Trial Registration: Iranian Registry of Clinical Trials: IRCT20160307026950N70

Schlagwörter

Stichwörter der Autor:innen

etomidateinjection painmidazolammyoclonusrandomized clinical trialtranscutaneous acupoint electrical stimulation

Autor:innen und Institutionen

  • Department of Anesthesiology and Critical Care School of Medicine Isfahan University of Medical Sciences Isfahan Iran mui.ac.ir.

ORCID-Profile: Mehran Rezvani Habibiabadi, Behzad Nazemroaya

Zitieren

APA

Habibiabadi, M. R., Nazemroaya, B., & Tanhaei, R. (2026). Comparing the Effects of Premedication With Low‐Dose Midazolam, Low‐Dose Etomidate, and Transcutaneous Acupoint Electrical Stimulation on Reducing Etomidate‐Induced Myoclonic Movements and Pain: A Single‐Blind Randomized Clinical Trial. Anesthesiology Research and Practice, 2026(1). https://doi.org/10.1155/anrp/5199717

Vancouver

Habibiabadi MR, Nazemroaya B, Tanhaei R. Comparing the Effects of Premedication With Low‐Dose Midazolam, Low‐Dose Etomidate, and Transcutaneous Acupoint Electrical Stimulation on Reducing Etomidate‐Induced Myoclonic Movements and Pain: A Single‐Blind Randomized Clinical Trial. Anesthesiology Research and Practice. 2026;2026(1). doi:10.1155/anrp/5199717

BibTeX
@article{Habibiabadi2026,
  author = {Habibiabadi, Mehran Rezvani and Nazemroaya, Behzad and Tanhaei, Reza},
  title = {Comparing the Effects of Premedication With Low‐Dose Midazolam, Low‐Dose Etomidate, and Transcutaneous Acupoint Electrical Stimulation on Reducing Etomidate‐Induced Myoclonic Movements and Pain: A Single‐Blind Randomized Clinical Trial},
  journal = {Anesthesiology Research and Practice},
  year = {2026},
  volume = {2026},
  number = {1},
  doi = {10.1155/anrp/5199717}
}
Kostenlos starten →